- The biopharma company plans to launch the first-ever crypto treasury around the Rain project.
- Enlivex sees long-term potential in Rain’s open-prediction market.
- Native RAI rallied after the news, up 110% within minutes.
The cryptocurrency market remained relatively stable on Monday, with Bitcoin holding above $86,000.
While most assets saw minor price actions, RAIN has decoupled with a sharp uptrend.
The altcoin has gained roughly 110% minutes after news that biopharmaceutical firm Enlivex Therapeutics plans to build a $212 million Rain-based crypto treasury.
NEWS: ENLIVEX completes a $212M digital asset treasury investment into $RAIN, a decentralized prediction markets protocol pioneering the next wave of prediction markets. Matteo Renzi, former Italian PM, joins the board.
— Ash Crypto (@AshCrypto) November 24, 2025
Reports suggest that the Nasdaq-listed company will complete the fundraise through PIPE (a private investment in public equity).
Notably, Enlivex will become the first institution to create a DAT (digital asset treasury) linked to a prediction-market crypto project.
The proposed raise involves Enlivex selling 212 million shares at $1 per share, with settlement in USDT and US dollars.
Meanwhile, the deal is expected to close by November 25, depending on final authorisations.
For a firm that focuses on immunotherapy research, dedicating millions to crypto reflects a bold move into the blockchain infrastructure.
Furthermore, the move adds credibility to RAIN as a legitimate token with serious value in the financial world.
The update flipped sentiments around the RAIN coin, catalysing a sharp rise minutes after the news surfaced.
Why the bold bet on Rain?
Talking with The Block, Enlivex board chairman Shai Novik highlighted Rain’s infrastructure as the scalable backbone that their firm has been pursuing.
He equalled Rain’s dominance in prediction markets to Uniswap in decentralised trading. Novik said:
For us, that open-architecture model represents the scalable growth engine we were looking for. We view Rain as the foundational infrastructure layer for the industry, similar to how Uniswap underpins decentralized trading.
That means Enlivex is more than just purchasing RAIN.
The biopharma is investing in a decentralized prediction-market model poised to transform on-chain information marketplaces.
A unique approach to reduce volatility
Indeed, cryptocurrency and volatility go hand in hand, and that has repelled many institutional players from interacting with digital tokens.
In that context, the Rain Foundation will back Enlivex’s DAT launch with a grant that adjusts the firm’s entry price, with 0.95 as the initial mNAV (modified net asset value).
That reduced early-stage volatility as the biopharma will have a stabilised baseline to start its DAT strategy.
RAIN price outlook
Rain’s native token led the gainers today.
The coin is trading at $0.007526 after a 110% uptick on its daily price chart.
The 66% surge in 24-hour trading volume indicates renewed appetite in RAIN.
While the alt eyes further uptrend, it can hardly decouple for long due to the prevailing broader selling pressure.
Therefore, RAIN remains prone to erasing part of its gains in the near term.
